Mowi ASA (OSE:MOWI): Q2 2026 Trading update

Mowi reported Q2 2026 harvest volume of 150k tonnes (GWT), up 13% vs 133k in Q2 2025 and a record-high for a second quarter, while operational EBIT rose 23% y/y to ~EUR 231m. Blended farming costs fell to EUR/kg 5.21 from EUR/kg 5.39 (down EUR/kg 0.18, ~EUR 24m). For Q2 2026, the company guided total harvest volume of ~140k GWT for the quarter associated with the Q1 2026 results, with the full Q2 report due 18 Aug.

Analysis

MOWI’s signal is less about a single quarter beat and more about operating leverage: higher throughput against a lower cost/kg base should expand cash conversion disproportionately, which matters because the stock is effectively a hybrid of commodity exposure and balance-sheet repair. That favors MOWI over purer spot-price beta names like SALM or BAKKA if investors start paying up for earnings durability rather than just salmon price torque. Downstream consumer products also softens the earnings cyclicality, so the market may be underpricing the quality of incremental EBITDA.

The second-order read-through is slightly negative for the industry price deck over the next 1-3 months: if a top producer is shipping more into the market, peers with less diversification will feel more pressure on realized pricing and inventory discipline. That is most relevant for the highest-cost operators and for retailers/foodservice that can use any easing in input costs to improve margins; it is less constructive for speculative long-only positions that need rising spot prices to re-rate. If salmon spot indices stay firm despite the volume increase, that would be the real bullish tell that demand elasticity is absorbing supply better than expected.

The main risks are biological and regulatory, not financial: a disease/mortality event, sea-lice pressure, or harsher quota/siting rules can flip the narrative within weeks, while pricing weakness is a 1-3 month catalyst. The contrarian view is that consensus may be too focused on the headline volume surprise and not enough on the fact that a modestly better mix and cost base can lift EPS even if the commodity backdrop is merely flat. The key falsifier is any August report that shows realized pricing or H2 biology deteriorating enough to offset the cost gains.

Key Decisions for Investors

• Long MOWI on pullbacks into the Aug. 18 report; target a 5-8% rerating over 1-3 months if consensus EPS revisions follow, with a stop if management hints at H2 price/mortality pressure.
• Pair trade: long MOWI / short SALM or BAKKA for 1-3 months to express better execution and diversification versus pure upstream beta; unwind if sector-wide spot prices strengthen and the relative thesis narrows.
• Buy MOWI call spreads into the full Q2 release if listed options liquidity is adequate; this is the cleanest way to capture an upside revision with defined downside before the event.
• Set an alert on European salmon spot prices and August guidance language; if spot prices fall sharply or H2 biomass commentary weakens, reduce exposure quickly because the thesis is mostly a near-term earnings revision trade.